Prion Diseases

Topic: Brain proteins, microglia and lab models

Purpose of review This article presents an update on the clinical aspects of human prion disease, including the wide spectrum of their presentations. Recent findings Prion diseases, a group of disorders caused by abnormally shaped proteins called prions, occur in sporadic (Jakob-Creutzfeldt disease), genetic (genetic Jakob-Creutzfeldt disease, Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia), and acquired (kuru, variant Jakob-Creutzfeldt disease, and iatrogenic Jakob-Creutzfeldt disease) forms. This article presents updated information on the clinical features and diagnostic methods for human prion diseases. New antemortem potential diagnostic tests based on amplifying prions in order to detect them are showing very high specificity. Understanding of the diversity of possible presentations of human prion diseases continues to evolve, with some genetic forms progressing slowly over decades, beginning with dysautonomia and neuropathy and progressing to a frontal-executive dementia with pathology of combined prionopathy and tauopathy. Unfortunately, to date, all human prion disease clinical trials have failed to show survival benefit. A very rare polymorphism in the prion protein gene recently has been identified that appears to protect against prion disease; this finding, in addition to providing greater understanding of the prionlike mechanisms of neurodegenerative disorders, might lead to potential treatments. Summary Sporadic Jakob-Creutzfeldt disease is the most common form of human prion disease. Genetic prion diseases, resulting from mutations in the prion-related protein gene (PRNP), are classified based on the mutation, clinical phenotype, and neuropathologic features and can be difficult to diagnose because of their varied presentations. Perhaps most relevant to this Continuum issue on neuroinfectious diseases, acquired prion diseases are caused by accidental transmission to humans, but fortunately, they are the least common form and are becoming rarer as awareness of transmission risk has led to implementation of measures to prevent such occurrences.

Key findings

• Unfortunately, to date, all human prion disease clinical trials have failed to show survival benefit.
• A very rare polymorphism in the prion protein gene recently has been identified that appears to protect against prion disease; this finding, in addition to providing greater understanding of the prionlike mechanisms of neurodegenerative disorders, might lead to potential treatments.
• Summary Sporadic Jakob-Creutzfeldt disease is the most common form of human prion disease.
• Genetic prion diseases, resulting from mutations in the prion-related protein gene (PRNP), are classified based on the mutation, clinical phenotype, and neuropathologic features and can be difficult to diagnose because of their varied presentations.
• Perhaps most relevant to this Continuum issue on neuroinfectious diseases, acquired prion diseases are caused by accidental transmission to humans, but fortunately, they are the least common form and are becoming rarer as awareness of transmission risk has led to implementation of measures to prevent such occurrences.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1212/con.0000000000000251
• PubMed: 26633779
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{geschwind2015-26633779,
  author  = {Geschwind, M. D.},
  title   = {{Prion Diseases}},
  journal = {Continuum (Minneapolis, Minn.)},
  year    = {2015},
  doi     = {10.1212/con.0000000000000251},
  pmid    = {26633779},
  url     = {https://doi.org/10.1212/con.0000000000000251}
}

Related studies in Disease mechanisms

• Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases International journal of molecular sciences · 2019-09-23 · usefulness score 39/100
• Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases Molecules (Basel, Switzerland) · 2015-12-18 · usefulness score 38/100
• Tau from SPAM Transgenic Mice Exhibit Potent Strain-Specific Prion-Like Seeding Properties Characteristic of Human Neurodegenerative Diseases NeuroMolecular Medicine · 2025-05-30 · usefulness score 37/100
• A novel prion disease associated with diarrhea and autonomic neuropathy The New England journal of medicine · 2013-11-01 · usefulness score 57/100
• Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature · 2009-02-01 · usefulness score 45/100
• Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons Nature neuroscience · 2012-07-22 · usefulness score 43/100

Similar studies

• Caregiver Burden in Prion Disease 2025 · Caregiving
• Neuroinflammation in Alzheimer's disease and prion disease 2002 · Inflammation and the immune system
• Palliative Care Resource Utilization in Patients with Prion Disease 2025 · End-of-life care
• Alzheimer's disease 2013 · Disease mechanisms
• Niemann-Pick diseases 2013 · Clinical safety
• RNA-binding proteins with prion-like domains in health and disease 2017 · Lewy body dementia

More on Disease mechanisms

• A review that covers this ground Prion-like Spreading in Tauopathies Biological psychiatry · 2017-04-13 · usefulness score 38/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →